Connection

YANG O HUH to Biomarkers, Tumor

This is a "connection" page, showing publications YANG O HUH has written about Biomarkers, Tumor.
Connection Strength

0.195
  1. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis. Am J Clin Pathol. 2004 Mar; 121(3):402-7.
    View in: PubMed
    Score: 0.060
  2. MYC protein expression is an important prognostic factor in acute myeloid leukemia. Leuk Lymphoma. 2019 01; 60(1):37-48.
    View in: PubMed
    Score: 0.040
  3. A case of multiple myeloma mimics: extensive bone metastasis of hepatocellular carcinoma without liver mass. Blood. 2016 Jan 21; 127(3):368.
    View in: PubMed
    Score: 0.034
  4. CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells. PLoS One. 2010 Dec 22; 5(12):e15183.
    View in: PubMed
    Score: 0.024
  5. C-kit receptor expression in acute leukemias-association with patient and disease characteristics and with outcome. Leuk Res. 2004 Apr; 28(4):373-8.
    View in: PubMed
    Score: 0.015
  6. CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia. Leuk Res. 2002 Jul; 26(7):643-9.
    View in: PubMed
    Score: 0.013
  7. Chronic lymphocytic leukemia With t(2;14)(p16;q32) involves the BCL11A and IgH genes and is associated with atypical morphologic features and unmutated IgVH genes. Am J Clin Pathol. 2009 May; 131(5):663-70.
    View in: PubMed
    Score: 0.005
  8. Advances in the diagnosis of acute leukemia. Hematol Oncol Clin North Am. 1993 Feb; 7(1):1-46.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.